Home » Newsletters » BioWorld Asia

BioWorld Asia

March 22, 2000

View Archived Issues

Other News To Note

GPC's Acquisition Of Mitotix Sees Transatlantic Firm Formed

More European Industry Attempts To Counter Anti-GM Prejudice

International Geneticists Identify Gene Causing Rare Dwarfism

Morphochem Acquires U.S.-Based Drug Screening Assay Developer

Genset Issues $10M In Shares To Abbott Laboratories

Vanguard, Wolfson Institute Expand Collaboration On CNS Treatments

Start-up Firm Files Patents On Gene-Profiling System

Promix Receives Venture Funds For Push In Rheumatoid Arthritis Area

Antisoma Prepares To Move Therex Into Phase IIa Breast Cancer Trials

NicOx Starts Phase I/II Trial Of Its Dermatology Drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...